focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 214.50
Bid: 214.50
Ask: 216.00
Change: 3.00 (1.42%)
Spread: 1.50 (0.699%)
Open: 205.00
High: 215.50
Low: 205.00
Prev. Close: 211.50
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

20 May 2014 07:00

RNS Number : 5053H
Advanced Medical Solutions Grp PLC
20 May 2014
 



 

20 May 2014

 

Advanced Medical Solutions Group plc

("AMS")

 

Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, will hold its Annual General Meeting ("AGM") at 11.00 today at the offices of Tavistock Communications, 131 Finsbury Pavement, London, EC2A 1NT.

 

Chris Meredith, AMS's Chief Executive Officer, will give a presentation at the AGM, the slides from which will be made available on the Company's website www.admedsol.com. No new material information will be provided.

 

In line with last year's practice, AMS will be providing an update on trading in late June.

 

- ends -

 

For further information, please contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

 

 

 

Tavistock Communications

Tel: +44 (0) 20 7920 3150

John West / Chris Munden / Andrew Dunn

 

 

 

Investec Bank plc

Tel: +44 (0) 20 7597 5970

Daniel Adams

 

 

About Advanced Medical Solutions Group plc - see www.admedsol.com 

 

Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$15 billion global wound care market. Through a mix of organic development and a number of acquisitions, AMS now has a wide range of products based on technologies that include alginates, silver alginates, foams, collagens, cyanoacrylate adhesives and sutures.

 

AMS manufactures wound care products for an extensive list of Original Equipment Manufacturer ("OEM") customers around the world, but the majority of the Group's revenues now come from its own brands - ActivHeal® wound care products in the UK to the NHS, LiquiBand® cyanoacrylate products primarily in the UK, Europe and the USA, and RESORBA® sutures and collagen wound care products primarily in Europe. AMS develops innovative products from its R&D pipeline which it commercialises globally, either directly or through partnerships with its OEM customers.

 

AMS's products are sold globally via a network of regional or multinational partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.

 

With 450 employees operating under four distinct business units (Branded Direct, Branded Distributed, OEM and Bulk Materials) that match its multiple products and routes-to-market, AMS's products are manufactured from two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFAFIUFLSESI
Date   Source Headline
22nd May 20137:00 amRNSAGM Statement
13th May 201311:53 amRNSHolding(s) in Company
22nd Apr 201312:33 pmRNSAnnual Financial Report
6th Mar 20137:00 amRNSFinal Results
26th Feb 20131:47 pmRNSNotice of Results
20th Feb 20132:49 pmRNSHolding(s) in Company
31st Jan 201311:41 amRNSTotal Voting Rights
18th Jan 20134:55 pmRNSHolding(s) in Company
16th Jan 20131:31 pmRNSHolding(s) in Company
31st Dec 20128:35 amRNSTotal Voting Rights
20th Dec 20125:43 pmRNSHolding(s) in Company
17th Dec 20125:18 pmRNSHolding(s) in Company
17th Dec 20122:37 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSTrading Update
30th Nov 20123:54 pmRNSTotal Voting Rights
31st Oct 20124:22 pmRNSTotal Voting Rights
28th Sep 20124:09 pmRNSTotal Voting Rights
7th Sep 20121:33 pmRNSDirector/PDMR Shareholding
5th Sep 20127:00 amRNSHalf Yearly Report
31st Aug 20124:00 pmRNSTotal Voting Rights
2nd Aug 20129:00 amRNSNotice of Results
31st Jul 20127:00 amRNSTotal Voting Rights
5th Jul 20122:45 pmRNSDirector/PDMR Shareholding
4th Jul 20121:56 pmRNSHolding(s) in Company
29th Jun 20125:39 pmRNSTotal Voting Rights
12th Jun 201212:15 pmRNSResult of AGM
12th Jun 20127:00 amRNSAGM Statement
31st May 20123:27 pmRNSTotal Voting Rights
11th May 20125:07 pmRNSTransaction in Own Shares
10th May 20121:50 pmRNSAnnual Financial Report
30th Apr 20129:35 amRNSTotal Voting Rights
16th Apr 20122:03 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSFinal Results
1st Mar 20127:00 amRNSNotice of Results
20th Jan 20124:41 pmRNSHolding(s) in Company
3rd Jan 201210:34 amRNSHolding(s) in Company
28th Dec 20117:42 amRNSHolding(s) in Company
22nd Dec 201112:11 pmRNSHolding(s) in Company
21st Dec 20113:16 pmRNSHolding(s) in Company
20th Dec 20118:20 amRNSCompletion of Acquisition
19th Dec 201111:58 amRNSResult of General Meeting
9th Dec 201111:33 amRNSHolding(s) in Company
9th Dec 201110:30 amRNSHolding(s) in Company
2nd Dec 20117:00 amRNSAcquisition of RESORBA
10th Nov 20119:46 amRNSInvestor Site Visit
19th Oct 20114:59 pmRNSHolding(s) in Company
17th Oct 201110:42 amRNSAdditional Listing
7th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20117:00 amRNSRe Agreement
1st Sep 20117:00 amRNSAgreement with Surgical Innovations Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.